IS6291A - Lausn sem inniheldur galantamín og sætuefni, til inntöku um munn - Google Patents
Lausn sem inniheldur galantamín og sætuefni, til inntöku um munnInfo
- Publication number
- IS6291A IS6291A IS6291A IS6291A IS6291A IS 6291 A IS6291 A IS 6291A IS 6291 A IS6291 A IS 6291A IS 6291 A IS6291 A IS 6291A IS 6291 A IS6291 A IS 6291A
- Authority
- IS
- Iceland
- Prior art keywords
- sweetener
- solution containing
- oral solution
- containing galantamine
- galantamine
- Prior art date
Links
- ASUTZQLVASHGKV-JDFRZJQESA-N galanthamine Chemical compound O1C(=C23)C(OC)=CC=C2CN(C)CC[C@]23[C@@H]1C[C@@H](O)C=C2 ASUTZQLVASHGKV-JDFRZJQESA-N 0.000 title 2
- 235000003599 food sweetener Nutrition 0.000 title 1
- 229960003980 galantamine Drugs 0.000 title 1
- ASUTZQLVASHGKV-UHFFFAOYSA-N galanthamine hydrochloride Natural products O1C(=C23)C(OC)=CC=C2CN(C)CCC23C1CC(O)C=C2 ASUTZQLVASHGKV-UHFFFAOYSA-N 0.000 title 1
- 229940100688 oral solution Drugs 0.000 title 1
- 239000003765 sweetening agent Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Addiction (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Psychology (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Saccharide Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP99203512 | 1999-10-26 | ||
| PCT/EP2000/010203 WO2001030318A1 (en) | 1999-10-26 | 2000-10-16 | Oral solution containing galanthamine and a sweetening agent |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IS6291A true IS6291A (is) | 2002-02-28 |
| IS2628B IS2628B (is) | 2010-05-15 |
Family
ID=8240778
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IS6291A IS2628B (is) | 1999-10-26 | 2002-02-28 | Lausn til inntöku sem inniheldur galantamín og sætumiðil |
Country Status (29)
| Country | Link |
|---|---|
| EP (1) | EP1237539B1 (is) |
| JP (1) | JP2003512415A (is) |
| KR (1) | KR100502391B1 (is) |
| CN (1) | CN1200691C (is) |
| AR (1) | AR026243A1 (is) |
| AT (1) | ATE306904T1 (is) |
| AU (1) | AU780826C (is) |
| BG (1) | BG65792B1 (is) |
| BR (1) | BR0015025A (is) |
| CA (1) | CA2388830C (is) |
| CZ (1) | CZ301996B6 (is) |
| DE (1) | DE60023341T2 (is) |
| DK (1) | DK1237539T3 (is) |
| EA (1) | EA005683B1 (is) |
| EE (1) | EE05230B1 (is) |
| ES (1) | ES2250211T3 (is) |
| HR (1) | HRP20020332B1 (is) |
| HU (1) | HUP0203484A3 (is) |
| IL (2) | IL149310A0 (is) |
| IS (1) | IS2628B (is) |
| MX (1) | MXPA02004149A (is) |
| NO (1) | NO332096B1 (is) |
| PL (1) | PL201694B1 (is) |
| SI (1) | SI1237539T1 (is) |
| SK (1) | SK285643B6 (is) |
| TW (1) | TW592725B (is) |
| UA (1) | UA76095C2 (is) |
| WO (1) | WO2001030318A1 (is) |
| ZA (1) | ZA200203313B (is) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030162770A1 (en) * | 2002-02-22 | 2003-08-28 | Davis Bonnie M. | Use of modulators of nicotinic receptors for treatment of cognitive dysfunction |
| US7297691B2 (en) | 2003-08-13 | 2007-11-20 | Janssen Pharmaceutica N.V. | Treatment of sleep disorders with cholinesterase inhibitors |
| US20050191349A1 (en) * | 2003-12-31 | 2005-09-01 | Garth Boehm | Galantamine formulations |
| US8709521B2 (en) * | 2007-05-22 | 2014-04-29 | The Coca-Cola Company | Sweetener compositions having enhanced sweetness and improved temporal and/or flavor profiles |
| US9708366B2 (en) * | 2011-01-27 | 2017-07-18 | Neuren Pharmaceuticals Ltd. | Treatment of fragile X syndrome using glycyl-L-2-methylprolyl-L-glutamate |
| US20140107130A1 (en) * | 2012-10-11 | 2014-04-17 | Antrim Pharmaceuticals, LLC | Oral Solution Formulations of Aripiprazole |
| JP6457582B2 (ja) * | 2017-04-14 | 2019-01-23 | エルメッド エーザイ株式会社 | ガランタミン含有医薬組成物、並びに医薬組成物におけるガランタミンの苦味抑制方法、及びガランタミンの苦味抑制剤 |
| CN117717558A (zh) * | 2023-12-06 | 2024-03-19 | 艾威药业(珠海)有限公司 | 加兰他敏及其药学上可接受的盐在制备治疗眼部疾病的药物中的应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4010079A1 (de) * | 1990-03-29 | 1991-10-02 | Lohmann Therapie Syst Lts | Pharmazeutische formulierung zur behandlung des alkoholismus |
| US5272137A (en) * | 1992-02-14 | 1993-12-21 | Mcneil-Pfc, Inc. | Aqueous pharmaceutical suspension for pharmaceutical actives |
| US6323195B1 (en) * | 1993-10-15 | 2001-11-27 | Aventis Pharmaceuticals Inc. | Galanthamine derivatives as acetylcholinesterase inhibitors |
| JPH10273435A (ja) * | 1997-01-29 | 1998-10-13 | Fujisawa Pharmaceut Co Ltd | 内服用液剤 |
-
2000
- 2000-10-16 AT AT00975872T patent/ATE306904T1/de active
- 2000-10-16 EE EEP200200213A patent/EE05230B1/xx unknown
- 2000-10-16 KR KR10-2002-7003258A patent/KR100502391B1/ko not_active Expired - Lifetime
- 2000-10-16 WO PCT/EP2000/010203 patent/WO2001030318A1/en not_active Ceased
- 2000-10-16 HU HU0203484A patent/HUP0203484A3/hu unknown
- 2000-10-16 SK SK530-2002A patent/SK285643B6/sk not_active IP Right Cessation
- 2000-10-16 JP JP2001532738A patent/JP2003512415A/ja active Pending
- 2000-10-16 UA UA2002054064A patent/UA76095C2/uk unknown
- 2000-10-16 MX MXPA02004149A patent/MXPA02004149A/es active IP Right Grant
- 2000-10-16 DE DE60023341T patent/DE60023341T2/de not_active Expired - Lifetime
- 2000-10-16 ES ES00975872T patent/ES2250211T3/es not_active Expired - Lifetime
- 2000-10-16 DK DK00975872T patent/DK1237539T3/da active
- 2000-10-16 TW TW089121526A patent/TW592725B/zh not_active IP Right Cessation
- 2000-10-16 AU AU13849/01A patent/AU780826C/en not_active Expired
- 2000-10-16 PL PL362849A patent/PL201694B1/pl unknown
- 2000-10-16 IL IL14931000A patent/IL149310A0/xx active IP Right Grant
- 2000-10-16 CN CNB008147388A patent/CN1200691C/zh not_active Expired - Lifetime
- 2000-10-16 BR BR0015025-8A patent/BR0015025A/pt not_active Application Discontinuation
- 2000-10-16 HR HR20020332A patent/HRP20020332B1/xx not_active IP Right Cessation
- 2000-10-16 SI SI200030782T patent/SI1237539T1/sl unknown
- 2000-10-16 EP EP00975872A patent/EP1237539B1/en not_active Expired - Lifetime
- 2000-10-16 CA CA002388830A patent/CA2388830C/en not_active Expired - Lifetime
- 2000-10-16 CZ CZ20021329A patent/CZ301996B6/cs not_active IP Right Cessation
- 2000-10-16 EA EA200200486A patent/EA005683B1/ru not_active IP Right Cessation
- 2000-10-25 AR ARP000105621A patent/AR026243A1/es not_active Application Discontinuation
-
2002
- 2002-02-28 IS IS6291A patent/IS2628B/is unknown
- 2002-03-20 BG BG106534A patent/BG65792B1/bg unknown
- 2002-04-24 IL IL149310A patent/IL149310A/en unknown
- 2002-04-25 ZA ZA200203313A patent/ZA200203313B/xx unknown
- 2002-04-26 NO NO20022003A patent/NO332096B1/no not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IS6263A (is) | Lyfjasamsetningar, sem innihalda trípeptíð | |
| ZA200202480B (en) | Oral dosage forms. | |
| HUP0202263A3 (en) | Benzimidazole, indole and imidazo-pyridine derivatives and pharmaceutical compositions containing them | |
| NO20021379D0 (no) | Benzodiazepin-derivater, fremstilling og anvendelse derav | |
| TR200003788A3 (tr) | Yavas salimli oral dozaj bilesim. | |
| DK1233943T3 (da) | Ioniserbare indolinon derivater og anvendelse deraf som PTK ligander | |
| NO20012567D0 (no) | Azepinoindolderivater, fremstilling og anvendelse derav | |
| IS2184B (is) | Lyfjaform með áfangalosun til inntöku um munn | |
| DK1180518T3 (da) | 5-pyridyl-1,3-azolforbindelser, fremgangsmåde til fremstilling deraf og anvendelse deraf | |
| NO20011216L (no) | Azetidinderivater, deres fremstilling og medikamenter inneholdende forbindelsene | |
| GB9930322D0 (en) | Rotating membrane | |
| ZA200007715B (en) | Stable extended release oral dosage composition. | |
| NO20006138L (no) | Substituerte indolinoner, fremstilling og anvendelse derav som medikamenter | |
| IL130022A0 (en) | Nefazodone dosage form | |
| ATE257159T1 (de) | Oral wirksame androgene | |
| EP1223175A4 (en) | SOLID AND LIQUID SWEETENER COMPOSITIONS AND THEIR USE | |
| IS2821B (is) | Amínóalkýlbensóýl-bensófúran eða bensóþíófenafleiður, aðferð til framleiðslu þeirra og samsetningar sem innihalda þær | |
| DK1057813T3 (da) | Indolderivater og medicinske sammensætninger indeholdende de samme | |
| GB9902687D0 (en) | Cryptographic protocol | |
| IS6291A (is) | Lausn sem inniheldur galantamín og sætuefni, til inntöku um munn | |
| ATE246502T1 (de) | Arzneiformen enthaltend carvedilol | |
| ID30397A (id) | Larutan oral prukaloprida | |
| NO20014853D0 (no) | Smakstilsetning | |
| CA85849S (en) | Evacuation handpiece | |
| GB9919622D0 (en) | Medical dummy |